NCT00837369View on ClinicalTrials.gov

Regadenoson R-T Perfusion Imaging Trial

PHASE1CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 7, 2009

Primary Completion Date

March 1, 2011

Study Completion Date

December 1, 2011

Conditions
Coronary Artery DiseaseMyocardial Perfusion Abnormalities
Interventions
DRUG

Regadenoson

400ug IV bolus injection, single dosage

Trial Locations (2)

55905

Mayo Clinic, Rochester

68105

University of Nebraska Medicial Center, Omaha

Sponsors
All Listed Sponsors
collaborator

Mayo Clinic

OTHER

collaborator

Astellas Pharma Inc

INDUSTRY

lead

University of Nebraska

OTHER